130 likes | 287 Views
What is eLife?. A collaboration between funders and the research community to improve research communication A researcher-led digital publication for outstanding work across the life sciences
E N D
What is eLife? • A collaboration between funders and the research community to improve research communication • A researcher-led digital publication for outstanding work across the life sciences • A platform to maximize the reach and influence of new research and to showcase new approaches for the presentation and assessment of research v11
eLife – scope • From the most basic and theoretical work through to translational, applied and clinical research. • Highly influential work that advances understanding, opens new doors or has real-world impacts. v11
eLife – goals • To make publishing more efficient, providing outstanding service through a swift, decisive and fair editorial process. • To exploit digital media in the presentation of research, increasing its utility for further research and broadening participation to the widest possible audience. • To drive open access by providing an outstanding new publishing option for ground-breaking research. • To catalyze change in research communication. v11
World-class backing • Supported by three of the world’s leading research funders • Effective research communication is a critical part of research • Editorially, eLife is entirely independent of the funders v11
Edited by researchers Editor-in-Chief - Randy Schekman, University of California at Berkeley (USA) Deputy Editor – Fiona Watt, King’s College London (UK) Deputy Editor – DetlefWeigel, Max Planck Institute for Developmental Biology (Germany) Senior Editors StylianosAntonarakis, University of Geneva Medical School (Switzerland) Ian Baldwin, Max Planck Institute for Chemical Ecology (Germany) Catherine Dulac, Harvard University (USA) Joe Goldstein, University of Texas Southwestern Medical Center (USA) Tony Hunter, Salk Institute (USA) PrabhatJha, University of Toronto (Canada) John Kuriyan, University of California at Berkeley (USA) Richard Losick, Harvard University (USA) James Manley, Columbia University (USA) Eve Marder, Brandeis University (USA) Michael Marletta, The Scripps Research Institute (USA) Chris Ponting, University of Oxford (UK) Janet Rossant, University of Toronto (Canada) Charles Sawyers, Memorial Sloan Kettering Cancer Center (USA) Tadatsugu Taniguchi, University of Tokyo (Japan) K. VijayRaghavan, National Center for Biological Sciences (India) Xiaodong Wang, National Institute of Biological Sciences (China) Huda Zoghbi, Baylor College of Medicine (USA) A 175-member Board of Reviewing Editors v11
A new approach to the editorial process Streamlined submission process prior to triage Limit submissions entering peer review Authors upload source files, including rich media and source data files where relevant Consultation amongst reviewers before decision The end result> A constructive process> Reduced times from submission to acceptance Single set of instructions – focused revision Limit rounds of revision v11
Selective but not exclusive • Interim findings may be published provided the conclusion is clear and the finding novel and of high importance • International Board of Reviewing Editors includes outstanding junior and experienced investigators • Fast turn-around for time-sensitive work • New and exciting findings will be published even if another paper comes out during revision v11
Born digital • No limits to article number • No (unnecessary) limits to article length • Use of rich media encouraged • Inclusion of underlying data • Supplementary information reserved for data/datasets • Added-value content to extend the reach of the work • Metrics and indicators of influence for all articles v11
Born free • Results will be available for free immediately on publication • Readers will have the right to use content without restriction, providing full author attribution (Creative Commons-Attribution license) • All content will also be deposited in PubMed Central Initially - also free of publication fees v11
eLife’s charter for authors • We commit to serving the interests of early-career researchers. • We commit to delivering an outstanding editorial service that is constructive, fair, swift, and decisive. • We commit to maximizing the influence of every author’s work, through effective promotion, open access, and adding value. • We commit to demonstrating the significance of each article through dynamic metrics and indicators of influence. eLife will help advance careers v11
Join us Randy Schekman Editor-in-chief schekman@berkeley.edu v11